Key Results from Clinical Study of NG101 for Semaglutide-Induced Nausea and Vomiting ...

New research shows that the same dopamine receptor mechanism responsible for drug addiction also governs the natural decline in motivation when we repeat rewarding behaviors.

A recent study published in Molecular Psychiatry suggests a new way to understand the relationship between body fat and the ...

Desensitization of neurons to dopamine is a well-known effect in addiction. However, researchers found a natural example of ...

In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors.

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

One philosophical view proposes that life is absurd. However, having hope and creating a purposeful life are correlated with ...

An oral small molecule drug may reduce gastrointestinal adverse events for adults using a GLP-1-based obesity drug, according ...

But there’s another feel-good neurotransmitter that’s gaining some attention on social media: anadamide. This compound, also ...

New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be ...

Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking semaglutide.